Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Changes in omentin levels and its mRNA expression in epicardial adipose tissue in patients undergoing elective cardiac surgery: the influence of type 2 diabetes and coronary heart disease.

Matloch Z, Kratochvílová H, Cinkajzlová A, Lipš M, Kopecký P, Pořízka M, Haluzíková D, Lindner J, Mráz M, Kloučková J, Lacinová Z, Haluzík M.

Physiol Res. 2018 Dec 18;67(6):881-890. Epub 2018 Sep 11.

2.

Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis.

Du Y, Ji Q, Cai L, Huang F, Lai Y, Liu Y, Yu J, Han B, Zhu E, Zhang J, Zhou Y, Wang Z, Zhao Y.

Cardiovasc Diabetol. 2016 Jun 28;15:90. doi: 10.1186/s12933-016-0406-5.

3.

Increased expression of the adipocytokine omentin in the epicardial adipose tissue of coronary artery disease patients.

Harada K, Shibata R, Ouchi N, Tokuda Y, Funakubo H, Suzuki M, Kataoka T, Nagao T, Okumura S, Shinoda N, Kato B, Sakai S, Kato M, Marui N, Ishii H, Amano T, Matsubara T, Murohara T.

Atherosclerosis. 2016 Aug;251:299-304. doi: 10.1016/j.atherosclerosis.2016.07.003. Epub 2016 Jul 6.

PMID:
27450783
4.

Serum concentrations and subcutaneous adipose tissue mRNA expression of omentin in morbid obesity and type 2 diabetes mellitus: the effect of very-low-calorie diet, physical activity and laparoscopic sleeve gastrectomy.

Urbanová M, Dostálová I, Trachta P, Drápalová J, Kaválková P, Haluzíková D, Matoulek M, Lacinová Z, Mráz M, Kasalický M, Haluzík M.

Physiol Res. 2014;63(2):207-18. Epub 2014 Jan 8.

5.

New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women.

Auguet T, Quintero Y, Riesco D, Morancho B, Terra X, Crescenti A, Broch M, Aguilar C, Olona M, Porras JA, Hernandez M, Sabench F, del Castillo D, Richart C.

BMC Med Genet. 2011 Apr 28;12:60. doi: 10.1186/1471-2350-12-60.

6.

[Expression of omentin in adipose tissues in obese and type 2 diabetic patients].

Cai RC, Wei L, DI JZ, Yu HY, Bao YQ, Jia WP.

Zhonghua Yi Xue Za Zhi. 2009 Feb 17;89(6):381-4. Chinese.

PMID:
19567114
7.

Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease.

Ji Q, Zhang J, Du Y, Zhu E, Wang Z, Que B, Miao H, Shi S, Qin X, Zhao Y, Zhou Y, Huang F, Nie S.

Cardiovasc Diabetol. 2017 Oct 16;16(1):133. doi: 10.1186/s12933-017-0612-9.

8.

Serum omentin 1 level is associated with coronary artery disease and its severity in postmenopausal women.

Onur I, Oz F, Yildiz S, Oflaz H, Sigirci S, Elitok A, Pilten S, Karaayvaz EB, Cizgici AY, Kaya MG, Onur ST, Sahin I, Dinckal HM.

Angiology. 2014 Nov;65(10):896-900. doi: 10.1177/0003319713511322. Epub 2013 Nov 21.

PMID:
24265251
9.

Association of serum omentin-1 levels with coronary artery disease.

Zhong X, Zhang HY, Tan H, Zhou Y, Liu FL, Chen FQ, Shang DY.

Acta Pharmacol Sin. 2011 Jul;32(7):873-8. doi: 10.1038/aps.2011.26. Epub 2011 May 23.

10.

Type 2 diabetes is associated with decreased PGC1α expression in epicardial adipose tissue of patients with coronary artery disease.

Moreno-Santos I, Pérez-Belmonte LM, Macías-González M, Mataró MJ, Castellano D, López-Garrido M, Porras-Martín C, Sánchez-Fernández PL, Gómez-Doblas JJ, Cardona F, de Teresa-Galván E, Jiménez-Navarro M.

J Transl Med. 2016 Aug 19;14(1):243. doi: 10.1186/s12967-016-0999-1.

11.

Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies.

Greulich S, Chen WJ, Maxhera B, Rijzewijk LJ, van der Meer RW, Jonker JT, Mueller H, de Wiza DH, Floerke RR, Smiris K, Lamb HJ, de Roos A, Bax JJ, Romijn JA, Smit JW, Akhyari P, Lichtenberg A, Eckel J, Diamant M, Ouwens DM.

PLoS One. 2013;8(3):e59697. doi: 10.1371/journal.pone.0059697. Epub 2013 Mar 29.

12.

Effect of atorvastatin on serum omentin-1 in patients with coronary artery disease.

Chen Q, Shang X, Yuan M, Liang L, Zhong X.

Coron Artery Dis. 2017 Jan;28(1):44-51.

PMID:
27749321
13.

Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis.

Gao X, Mi S, Zhang F, Gong F, Lai Y, Gao F, Zhang X, Wang L, Tao H.

Cardiovasc Diabetol. 2011 Oct 7;10:87. doi: 10.1186/1475-2840-10-87.

14.

Association of omentin Val109Asp polymorphism with coronary artery disease.

Yörük U, Yaykaşli KO, Özhan H, Memişoğullari R, Karabacak A, Bulur S, Aslantaş Y, Başar C, Kaya E.

Anadolu Kardiyol Derg. 2014 Sep;14(6):511-4. doi: 10.5152/akd.2013.4932. Epub 2013 Dec 19.

15.

Serum levels of chemerin, apelin, vaspin, and omentin-1 in obese type 2 diabetic Egyptian patients with coronary artery stenosis.

Motawi TMK, Mahdy SG, El-Sawalhi MM, Ali EN, El-Telbany RFA.

Can J Physiol Pharmacol. 2018 Jan;96(1):38-44. doi: 10.1139/cjpp-2017-0272. Epub 2017 Sep 28.

PMID:
28957639
16.

Omentin-1 is decreased in maternal plasma, placenta and adipose tissue of women with pre-existing obesity.

Barker G, Lim R, Georgiou HM, Lappas M.

PLoS One. 2012;7(8):e42943. doi: 10.1371/journal.pone.0042943. Epub 2012 Aug 28.

17.

High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis.

Saely CH, Leiherer A, Muendlein A, Vonbank A, Rein P, Geiger K, Malin C, Drexel H.

Atherosclerosis. 2016 Jan;244:38-43. doi: 10.1016/j.atherosclerosis.2015.10.100. Epub 2015 Oct 30.

PMID:
26590865
18.

Fibroblast growth factor-21 and omentin-1 hepatic mRNA expression and serum levels in morbidly obese women with non-alcoholic fatty liver disease.

Waluga M, Kukla M, Zorniak M, Kajor M, Liszka L, Dyaczynski M, Kowalski G, Zadlo D, Waluga E, Olczyk P, Buldak RJ, Berdowska A, Hartleb M.

J Physiol Pharmacol. 2017 Jun;68(3):363-374.

19.

Adipose Tissue-Derived Omentin-1 Function and Regulation.

Watanabe T, Watanabe-Kominato K, Takahashi Y, Kojima M, Watanabe R.

Compr Physiol. 2017 Jun 18;7(3):765-781. doi: 10.1002/cphy.c160043. Review.

PMID:
28640441
20.

Omentin: linking metabolic syndrome and cardiovascular disease.

Zhou JY, Chan L, Zhou SW.

Curr Vasc Pharmacol. 2014 Jan;12(1):136-43. Review.

PMID:
22724476

Supplemental Content

Support Center